TA
MDT icon

Tamarack Advisers’s Medtronic MDT Stock Holding History

Tamarack Advisers’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,500
Closed -$68K – 64
2021
Q1 		$68K Buy
+2,500
New +$293K 0.01% 66
2020
Q4 		– Sell
-2,000
Closed -$334K – 48
2020
Q3 		$334K Buy
+2,000
New +$201K 0.1% 33

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tamarack Advisers's MDT Position: Q2 2022 in Review

Tamarack Advisers sold out of Medtronic (MDT) in Q2 2022, closing a stake of 75,000 shares — an estimated $8.32M sold.

Tamarack Advisers first reported a position in MDT in Q4 2015 and held it in 24 quarters. The position peaked at $43.8M in Q4 2019. 2,022 funds tracked by Wall St. Rank hold MDT as of Q2 2022.

  • Tamarack Advisers reported no remaining Medtronic position as of Q2 2022 after selling out during the quarter.
  • Tamarack Advisers sold 75,000 Medtronic shares in Q2 2022, an estimated $8.32M.
  • Tamarack Advisers first reported a position in Medtronic in Q4 2015 and held it in 24 quarters.
  • Tamarack Advisers's Medtronic position peaked at $43.8M in Q4 2019.
  • 2,022 funds tracked by Wall St. Rank held Medtronic as of Q2 2022.

Based on Tamarack Advisers's 13F filing for Q2 2022, filed 16 Aug 2022.